title: Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients?
authors.forename: Roosmarijn C
authors.initials: RC
authors.lastname: Drexhage
authors.forename: Roos C
authors.initials: RC
authors.lastname: Padmos
authors.forename: Harm
authors.initials: H
authors.lastname: de Wit
authors.forename: Marjan A
authors.initials: MA
authors.lastname: Versnel
authors.forename: Herbert
authors.initials: H
authors.lastname: Hooijkaas
authors.forename: Aart-Jan
authors.initials: AJ
authors.lastname: van der Lely
authors.forename: Nico
authors.initials: N
authors.lastname: van Beveren
authors.forename: Roel H
authors.initials: RH
authors.lastname: deRijk
authors.forename: Dan
authors.initials: D
authors.lastname: Cohen
mesh_terms: D000328:Adult; D018932:Chemokine CCL2 / Q000097:blood*; D002630:Chemotactic Factors / Q000097:blood*; D002908:Chronic Disease; D015897:Comorbidity; D035061:Control Groups; D005260:Female; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood* / Q000453:epidemiology; D009426:Netherlands / Q000453:epidemiology; D015995:Prevalence; D012559:Schizophrenia / Q000097:blood* / Q000453:epidemiology
chemical_list: D018932:Chemokine CCL2; D002630:Chemotactic Factors